$KNW
KNOW LABS, INC. Stock $knw

$knw Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000165495421013414 Filed on December 21, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2021
Revenue	$4.351M	$0.00	$0.00
YoY Change			-100.0%
Cost Of Revenue		$0.00	$0.00
YoY Change			-100.0%
Gross Profit		$0.00	$0.00
YoY Change			-100.0%
Gross Profit Margin
Selling, General & Admin	$1.217M	$1.542M	$6.476M
YoY Change	-53.17%	-6.43%	33.68%
% of Gross Profit
Research & Development	$885.8K	$875.9K	$3.970M
YoY Change	-8.39%	21.62%	95.21%
% of Gross Profit
Depreciation & Amortization	$41.67K	$34.72K	$200.8K
YoY Change	-35.53%	-56.0%	-17.36%
% of Gross Profit
Operating Expenses	$3.118M	$2.418M	$10.45M
YoY Change		1.3%	51.87%
Operating Profit	-$869.7K	-$2.418M	-$10.45M
YoY Change	-75.61%	1.3%	53.04%
Interest Expense	$4.487M	-$5.178M	$14.91M
YoY Change	158.8%	169.06%	144.71%
% of Operating Profit
Other Income/Expense, Net	-$4.487M	$0.00	-$14.91M
YoY Change	158.8%	-100.0%	121.38%
Pretax Income	-$5.357M	-$7.596M	-$25.36M
YoY Change	1.08%	76.17%	86.99%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.357M	-$7.596M	-$25.36M
YoY Change	1.08%	76.17%	86.99%
Net Earnings / Revenue	-123.1%
Basic Earnings Per Share
Diluted Earnings Per Share	-$151.0K	-$220.0K	-$863.5K
COMMON SHARES
Basic Shares Outstanding	35.97M shares	34.43M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q4	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.73M	$12.26M	$12.26M
YoY Change	266.69%	185.2%	185.2%
Cash & Equivalents	$10.73M	$12.26M	$12.26M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$3.125M	$0.00	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$13.86M	$12.26M	$12.26M
YoY Change	373.43%	185.2%	185.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$672.3K	$328.5K	$617.5K
YoY Change	214.64%	155.31%	139.65%
Goodwill
YoY Change
Intangibles		$0.00
YoY Change		-100.0%
Long-Term Investments
YoY Change
Other Assets	$13.77K	$13.77K	$13.77K
YoY Change	-45.31%	-45.31%	-45.31%
Total Long-Term Assets	$1.027M	$631.3K	$631.3K
YoY Change	246.05%	64.41%	64.41%
TOTAL ASSETS
Total Short-Term Assets	$13.86M	$12.26M	$12.26M
Total Long-Term Assets	$1.027M	$631.3K	$631.3K
Total Assets	$14.88M	$12.89M	$12.89M
YoY Change	361.71%	175.29%	175.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$408.5K	$419.1K	$419.1K
YoY Change	-29.66%	-15.08%	-15.08%
Accrued Expenses	$1.508M	$893.1K	$1.427M
YoY Change	27.98%	122.63%	29.55%
Deferred Revenue
YoY Change
Short-Term Debt	$13.38M	$9.191M	$9.191M
YoY Change	153.78%	131.66%	131.66%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.42M	$11.04M	$11.04M
YoY Change	121.38%	73.88%	73.88%
LONG-TERM LIABILITIES
Long-Term Debt	$431.8K	$431.8K	$431.8K
YoY Change		90.92%	90.92%
Other Long-Term Liabilities	$171.6K	$178.2K	$178.2K
YoY Change	1075.21%	665.99%	665.99%
Total Long-Term Liabilities	$603.4K	$610.0K	$610.0K
YoY Change	4032.77%	144.55%	144.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.42M	$11.04M	$11.04M
Total Long-Term Liabilities	$603.4K	$610.0K	$610.0K
Total Liabilities	$18.03M	$11.65M	$11.65M
YoY Change	128.62%	76.55%	76.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$86.68M	-$81.33M
YoY Change		45.31%
Common Stock	$35.97K	$35.17K
YoY Change		41.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.141M	$1.242M	$1.242M
YoY Change
Total Liabilities & Shareholders Equity	$14.88M	$12.89M	$12.89M
YoY Change	361.71%	175.29%	175.29%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	-$5.357M	-$7.596M	-$25.36M
YoY Change	1.08%	76.17%	86.99%
Depreciation, Depletion And Amortization	$41.67K	$34.72K	$200.8K
YoY Change	-35.53%	-56.0%	-17.36%
Cash From Operating Activities	-$1.908M	-$1.706M	-$6.851M
YoY Change	34.26%	36.75%	75.04%
INVESTING ACTIVITIES
Capital Expenditures	-$385.5K	-$252.0K	-$299.5K
YoY Change	3903.01%	341.53%	327.11%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$385.5K	-$252.0K	-$299.5K
YoY Change	3901.74%	341.53%	327.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.344K		$23.34K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$768.8K	346.2K	$15.11M
YoY Change	1188.08%	-63.19%	136.79%
NET CHANGE
Cash From Operating Activities	-$1.908M	-1.706M	-$6.851M
Cash From Investing Activities	-$385.5K	-252.0K	-$299.5K
Cash From Financing Activities	$768.8K	346.2K	$15.11M
Net Change In Cash	-$1.524M	-1.612M	$7.960M
YoY Change	11.2%	342.63%	232.04%
FREE CASH FLOW
Cash From Operating Activities	-$1.908M	-$1.706M	-$6.851M
Capital Expenditures	-$385.5K	-$252.0K	-$299.5K
Free Cash Flow	-$1.522M	-$1.454M	-$6.551M
YoY Change	7.86%	22.14%	70.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35969912	shares
CY2021Q3	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	12258218	USD
CY2020Q3	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	4298179	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	12258218	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	4298179	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328504	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	128671	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	101114	USD
CY2021Q3	us-gaap	Other Assets OtherAssets	13767	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	25180	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	289002	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	129003	USD
CY2021Q3	us-gaap	Assets Assets	12889491	USD
CY2020Q3	us-gaap	Assets Assets	4682147	USD
CY2021Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	419093	USD
CY2020Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	493497	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	401178	USD
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	421599	USD
CY2020Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	591600	USD
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	9191155	USD
CY2020Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3967578	USD
CY2021Q3	knwn	Simple Agreements For Future Equity Current SimpleAgreementsForFutureEquityCurrent	0	USD
CY2020Q3	knwn	Simple Agreements For Future Equity Current SimpleAgreementsForFutureEquityCurrent	785000	USD
CY2021Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	431803	USD
CY2020Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	0	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	112371	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	108779	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11469158	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	893137	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6347632	USD
CY2021Q3	knwn	Notes Payable Ppp Loans NotesPayablePppLoans	0	USD
CY2020Q3	knwn	Notes Payable Ppp Loans NotesPayablePppLoans	226170	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178170	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23256	USD
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	178170	USD
CY2020Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	249426	USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35166551	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24804874	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	35168	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	24807	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	82530684	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54023758	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81326494	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55966281	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1242163	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-1914911	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12889491	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4682147	USD
CY2021	us-gaap	Revenues Revenues	0	USD
CY2020	us-gaap	Revenues Revenues	121939	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	69726	USD
CY2021	us-gaap	Gross Profit GrossProfit	0	USD
CY2020	us-gaap	Gross Profit GrossProfit	52213	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3969972	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2033726	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6476176	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4844415	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10446148	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-6825928	USD
CY2021	us-gaap	Interest Expense InterestExpense	14914065	USD
CY2020	us-gaap	Interest Expense InterestExpense	6094682	USD
CY2021	us-gaap	Other Income OtherIncome	0	USD
CY2020	us-gaap	Other Income OtherIncome	65769	USD
CY2021	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-707800	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14914065	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6736713	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-25360213	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-13562641	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-25360213	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13562641	USD
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.86
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.62
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29370596	shares
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	21791058	shares
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	-3297290	USD
CY2020	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	1702085	USD
CY2020	knwn	Stock Option Exercise Amount StockOptionExerciseAmount	0	USD
CY2020	knwn	Issuance Of Warrants For Services Related To Debt Offering Note7 Amount IssuanceOfWarrantsForServicesRelatedToDebtOfferingNote7Amount	4596537	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3766074	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1824998	USD
CY2020	knwn	Conversion Of Debt Offering And Accrued Interest Shares ConversionOfDebtOfferingAndAccruedInterestShares	975326	shares
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1045000	USD
CY2020	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	85000	USD
CY2020	knwn	Issuance Of Shares Related To Settlement And Mutual Release And Subscription Agreements Amount IssuanceOfSharesRelatedToSettlementAndMutualReleaseAndSubscriptionAgreementsAmount	950000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13562641	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-1914911	USD
CY2021	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	1028522	USD
CY2021	knwn	Issuance Of Warrants For Services Related To Debt Offering Note7 Amount IssuanceOfWarrantsForServicesRelatedToDebtOfferingNote7Amount	6098058	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	9769683	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	4439317	USD
CY2021	knwn	Issuance Of Warrants For Services Related To Debt Offering Note Amount IssuanceOfWarrantsForServicesRelatedToDebtOfferingNoteAmount	1667281	USD
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	202820	USD
CY2021	knwn	Issuance Of Warrant For Services IssuanceOfWarrantForServices	2547436	USD
CY2021	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	1313203	USD
CY2021	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	23344	USD
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1427622	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1242163	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-25360213	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13562641	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200807	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	242987	USD
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	202820	USD
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1045000	USD
CY2021	knwn	Stock Compensation Expense Warrants StockCompensationExpenseWarrants	-2547436	USD
CY2020	knwn	Stock Compensation Expense Warrants StockCompensationExpenseWarrants	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1028522	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1702085	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13722672	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5662690	USD
CY2021	knwn	Right Of Use Net RightOfUseNet	-1493	USD
CY2020	knwn	Right Of Use Net RightOfUseNet	422	USD
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4663	USD
CY2021	knwn	Noncash Gain On Accounts Payable NoncashGainOnAccountsPayable	0	USD
CY2021	us-gaap	Derivatives Methods Of Accounting Hedge Effectiveness DerivativesMethodsOfAccountingHedgeEffectiveness	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Derivative Financial Instruments –</strong>Pursuant to ASC 815 “Derivatives and Hedging”, the Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company then determines if embedded derivative must be bifurcated and separately accounted for. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined that the conversion features for purposes of bifurcation within its currently outstanding convertible notes payable were immaterial and there was no derivative liability to be recorded as of September 30, 2021 and 2020.</p>
CY2021	knwn	Loss Related To Issuance Of Shares For Debt Settlement LossRelatedToIssuanceOfSharesForDebtSettlement	0	USD
CY2020	knwn	Loss Related To Issuance Of Shares For Debt Settlement LossRelatedToIssuanceOfSharesForDebtSettlement	825000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Use of Estimates</strong> – The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-63049	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-70134	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	14209000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	0	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-6435	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7103	USD
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	11413	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-11414	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	797337	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	218018	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6850699	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3913803	USD
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	299525	USD
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	70134	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-299525	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5639500	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	727117	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	479965	USD
CY2021	knwn	Proceeds From Simple Agreements For Future Equity ProceedsFromSimpleAgreementsForFutureEquity	340000	USD
CY2020	knwn	Proceeds From Simple Agreements For Future Equity ProceedsFromSimpleAgreementsForFutureEquity	785000	USD
CY2021	knwn	Repayment From Simple Agreements For Future Equity RepaymentFromSimpleAgreementsForFutureEquity	-253800	USD
CY2020	knwn	Repayment From Simple Agreements For Future Equity RepaymentFromSimpleAgreementsForFutureEquity	0	USD
CY2021	knwn	Proceeds From Note Payableppp ProceedsFromNotePayableppp	205633	USD
CY2020	knwn	Proceeds From Note Payableppp ProceedsFromNotePayableppp	226170	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	23344	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1313203	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	85575	USD
CY2021	knwn	Proeeds From Issuance Of Shares Related To Debt Settlement ProeedsFromIssuanceOfSharesRelatedToDebtSettlement	0	USD
CY2020	knwn	Proeeds From Issuance Of Shares Related To Debt Settlement ProeedsFromIssuanceOfSharesRelatedToDebtSettlement	125000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15110263	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6381280	USD
CY2021	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7960039	USD
CY2020	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2397343	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298179	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1900836	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12258218	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298179	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	18800	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1922	USD
CY2021	knwn	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature1 AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1	9769683	USD
CY2020	knwn	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature1 AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1	3766074	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	4439317	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1824998	USD
CY2021	knwn	Adjustments To Additional Paid In Capital Warrant Issued For Services AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices	1667281	USD
CY2020	knwn	Adjustments To Additional Paid In Capital Warrant Issued For Services AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServices	975326	USD
CY2021	knwn	Cashless Warrant Exercise CashlessWarrantExercise	515975	USD
CY2020	knwn	Cashless Warrant Exercise CashlessWarrantExercise	111554	USD
CY2021	knwn	Cashless Stock Options Exercise CashlessStockOptionsExercise	0	USD
CY2020	knwn	Cashless Stock Options Exercise CashlessStockOptionsExercise	18298	USD
CY2021	knwn	Conversion Of Debt Offering ConversionOfDebtOffering	5638275	USD
CY2020	knwn	Conversion Of Debt Offering ConversionOfDebtOffering	4245448	USD
CY2021	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	460185	USD
CY2020	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	351089	USD
CY2021	knwn	Issuance Of Shares And Warrants For Conversion Of Simple Agreements For Future Equity IssuanceOfSharesAndWarrantsForConversionOfSimpleAgreementsForFutureEquity	1427141	USD
CY2020	knwn	Issuance Of Shares And Warrants For Conversion Of Simple Agreements For Future Equity IssuanceOfSharesAndWarrantsForConversionOfSimpleAgreementsForFutureEquity	0	USD
CY2021Q3	knwn	Authorized Shares Of Capital Common Stock AuthorizedSharesOfCapitalCommonStock	105000000	shares
CY2020Q3	knwn	Authorized Shares Of Capital Common Stock AuthorizedSharesOfCapitalCommonStock	100000000	shares
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	knwn	Authorized Common Stock Increased AuthorizedCommonStockIncreased	200000000	shares
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12258218	USD
CY2021Q3	knwn	Working Capital WorkingCapital	10092586	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81326494	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	14209000	USD
CY2021Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2021Q1	knwn	Warrants In Private Placement To Accredited Investors WarrantsInPrivatePlacementToAccreditedInvestors	3552250	shares
CY2021Q1	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	2
CY2021Q3	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	USD
CY2021Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	12008228	USD
CY2020Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4048179	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3969972	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2033726	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	329375	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	230844	USD
CY2021Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	12217714	USD
CY2020Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	4252959	USD
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35166551	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	16124764	shares
CY2020Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	7894566	shares
CY2021Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	USD
CY2020Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	USD
CY2021Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	654798	USD
CY2020Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	355272	USD
CY2021Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	USD
CY2020Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	356761	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	257068	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328504	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	128671	USD
CY2021	us-gaap	Depreciation Depreciation	99693	USD
CY2020	us-gaap	Depreciation Depreciation	69655	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	101114	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	173332	USD
CY2021	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	520000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	291000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	290000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	132000	USD
CY2021	us-gaap	Lease Cost LeaseCost	139643	USD
CY2020	us-gaap	Lease Cost LeaseCost	136718	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	139643	USD
CY2021	knwn	Finance Leases Weighted Average Remaining Lease Term FinanceLeasesWeightedAverageRemainingLeaseTerm	P28Y
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	128987	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	107662	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	73095	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	USD
CY2021Q3	knwn	Total Remaining Payments TotalRemainingPayments	309744	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19203	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	290541	USD
CY2021Q3	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-9881990	USD
CY2020Q3	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-4242490	USD
CY2021Q3	knwn	Debt Discount Beneficial Conversion Feature DebtDiscountBeneficialConversionFeature	-4308337	USD
CY2020Q3	knwn	Debt Discount Beneficial Conversion Feature DebtDiscountBeneficialConversionFeature	-2127894	USD
CY2021Q3	knwn	Debt Discount Warrants DebtDiscountWarrants	-1957590	USD
CY2020Q3	knwn	Debt Discount Warrants DebtDiscountWarrants	-1025512	USD
CY2021Q3	knwn	Debt Discount Warrants Issued For Services DebtDiscountWarrantsIssuedForServices	-1056984	USD
CY2020Q3	knwn	Debt Discount Warrants Issued For Services DebtDiscountWarrantsIssuedForServices	-823582	USD
CY2021Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	9191155	USD
CY2020Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	3967578	USD
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1045000	USD
CY2021Q3	knwn	Options To Purchase Common Stock Share OptionsToPurchaseCommonStockShare	15315120	shares
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned	11775745	shares
CY2021Q3	knwn	Warrant Issued To Common Stock WarrantIssuedToCommonStock	22564255	shares
CY2020Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	9020264	shares
CY2021Q3	knwn	Conversion Of Convertible Debentures ConversionOfConvertibleDebentures	16464066	USD
CY2021Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	16464066	USD
CY2021Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	16124764	shares
CY2020Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	9020264	USD
CY2021	knwn	Common Stock Restricted Shares Issued For Services CommonStockRestrictedSharesIssuedForServices	550000	shares
CY2021Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.90
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35166551	shares
CY2020Q3	us-gaap	Share Price SharePrice	0.889
CY2021	knwn	Shareholders Paid ShareholdersPaid	125000	USD
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	500000	shares
CY2020	knwn	Loss Related To Issuance Of Shares For Debt Settlement LossRelatedToIssuanceOfSharesForDebtSettlement	825000	USD
CY2020Q3	knwn	Shareholders Paid ShareholdersPaid	125000	USD
CY2020Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.155
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2819750	USD
CY2020Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.20
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20016367	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6608789	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.117
CY2021	knwn	Stock Issued During Period Shares Stock Option Exercised StockIssuedDuringPeriodSharesStockOptionExercised	-3676542	shares
CY2021	knwn	Share Based Compensation Arrangements By Share Based Payment Award Option Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionExercisesInPeriodWeightedAverageExercisePrice	-0.582
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	384359	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22564255	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.998
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	22564255	shares
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	22554255	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	34314540	USD
CY2020	knwn	Stock Option Grants StockOptionGrants	2739477	shares
CY2020Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	2.593
CY2019Q4	knwn	Common Stock For Vested Stock Option CommonStockForVestedStockOption	73191	shares
CY2019Q4	knwn	Common Stock For Vested Stock Option Totaling CommonStockForVestedStockOptionTotaling	93750	shares
CY2019Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.25
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1028522	USD
CY2020	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1702085	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1312936	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y9M25D
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9180369	USD
CY2020	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossGranted	3522400	USD
CY2020	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossExercised	-18298	USD
CY2020	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options In Period Gross Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriodGrossForfeitures	-7103921	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5580550	USD
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossGranted	18807990	USD
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossExercised	-28031	USD
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options In Period Gross Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriodGrossForfeitures	-396000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23964509	USD
CY2021	knwn	Summarize Information About Particle Stock Option And Exercisabletabletextblock SummarizeInformationAboutParticleStockOptionAndExercisabletabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Weighted </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Weighted </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Weighted </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Average</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Average</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Average</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Range of</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Number</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Remaining Life </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Exercise Price</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Number</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Exercise Price</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Exercise Prices</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Outstanding</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">In Years</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Outstanding</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Exerciseable</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Exerciseable</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">230,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">1.71</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">0.250</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:13%;vertical-align:bottom;text-align:right;">172,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:13%;vertical-align:bottom;text-align:right;">0.250</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">1.10-1.25</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,074,375</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.15</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1.108</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">445,456</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1.105</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">1.28-1.53</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">9,480,745</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.58</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1.499</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">993,750</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1.307</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">1.79-3.67</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">2,530,000</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">4.64</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">2.192</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">108,750</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">1.895</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">15,315,120</p></td><td style="PADDING-BOTTOM: 1px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.82 </p></td><td style="PADDING-BOTTOM: 1px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">$</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.565</p></td><td style="PADDING-BOTTOM: 1px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 1,720,456</p></td><td style="PADDING-BOTTOM: 1px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">$</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.316</p></td><td style="PADDING-BOTTOM: 1px;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M24D
CY2021Q3	knwn	Weighted Average Exercise Price Outstanding WeightedAverageExercisePriceOutstanding	1.565
CY2021Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1720456	shares
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1.316
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.80
CY2017Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	3334	USD
CY2019Q1	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	8697	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	6500000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	5100000	USD
CY2021Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	43800000	USD
CY2021	knwn	Net Operating Loss Carryforwards Expiration Dates NetOperatingLossCarryforwardsExpirationDates	2028-2041
CY2021Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9700000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8000000.0	USD
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	8051000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	6536000	USD
CY2021Q3	knwn	Stock Based Compensation StockBasedCompensation	975000	USD
CY2020Q3	knwn	Stock Based Compensation StockBasedCompensation	1196000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	276000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	305000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	399000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	11000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9701000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8048000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9701000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8048000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1653000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1092357	USD
CY2021	knwn	Income Tax Provision At Statutory Rate IncomeTaxProvisionAtStatutoryRate	-0.210	pure
CY2020	knwn	Income Tax Provision At Statutory Rate IncomeTaxProvisionAtStatutoryRate	-0.210	pure
CY2021	knwn	Warrant Interest Expense WarrantInterestExpense	0.12	pure
CY2020	knwn	Warrant Interest Expense WarrantInterestExpense	0.09	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.07	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.09	pure
CY2021	knwn	Prior Year True Up PriorYearTrueUp	0.02	pure
CY2020	knwn	Prior Year True Up PriorYearTrueUp	0.03	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	knwn	Segment Revenues SegmentRevenues	0	USD
CY2021	knwn	Segment Gross Profit SegmentGrossProfit	0	USD
CY2021	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-10446000	USD
CY2021Q3	knwn	Segment Assets SegmentAssets	12889000	USD
CY2020	knwn	Segment Revenues SegmentRevenues	122000	USD
CY2020	knwn	Segment Gross Profit SegmentGrossProfit	70000	USD
CY2020	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-6826000	USD
CY2020Q3	knwn	Segment Assets SegmentAssets	4682000	USD
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	3979584	USD
CY2020	us-gaap	Other Noncash Expense OtherNoncashExpense	2990072	USD

Files In Submission

Name	View Source	Status
0001654954-21-013414-index-headers.html	Edgar Link	pending
0001654954-21-013414-index.html	Edgar Link	pending
0001654954-21-013414.txt	Edgar Link	pending
0001654954-21-013414-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
knwn-20210930.xsd	Edgar Link	pending
knwn-20210930_cal.xml	Edgar Link	unprocessable
knwn-20210930_def.xml	Edgar Link	unprocessable
knwn-20210930_lab.xml	Edgar Link	unprocessable
knwn-20210930_pre.xml	Edgar Link	unprocessable
knwn_10k.htm	Edgar Link	pending
knwn_10kimg18.jpg	Edgar Link	pending
knwn_10k_htm.xml	Edgar Link	completed
knwn_ex211.htm	Edgar Link	pending
knwn_ex311.htm	Edgar Link	pending
knwn_ex312.htm	Edgar Link	pending
knwn_ex321.htm	Edgar Link	pending
knwn_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KNW
KNOW LABS, INC. Stock $knw

2021 Q4 Form 10-K Financial Statement

#000165495421013414 Filed on December 21, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW KNOW LABS, INC. Stock $knw

2021 Q4 Form 10-K Financial Statement

#000165495421013414 Filed on December 21, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW
KNOW LABS, INC. Stock $knw